The MASCC/ISOO Mucositis Guidelines: Dissemination and clinical impact

Supportive Care in Cancer

Volumn 21, Issue 11, 2013, Pages 3161-3163

  Lalla, Rajesh V ^a   Ashbury, Fredrick D ^b,c,d  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b UNIVERSITY OF WOLLONGONG   (Australia)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMIFOSTINE; ANALGESIC AGENT; ANTIINFLAMMATORY AGENT; BENZYDAMINE; BICARBONATE; CYTOKINE; GLUTAMINE; GROWTH FACTOR; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; MOUTHWASH; PENTOXIFYLLINE; PILOCARPINE; ZINC;

CANCER PATIENT; CANCER RADIOTHERAPY; CRYOTHERAPY; DIGESTIVE SYSTEM INFLAMMATION; DISEASE SEVERITY; DRUG EFFICACY; EDITORIAL; GASTROINTESTINAL MUCOSA; GASTROINTESTINAL SYMPTOM; GOOD CLINICAL PRACTICE; HEAD AND NECK CANCER; HUMAN; INFORMATION DISSEMINATION; MOUTH DISEASE; MOUTH HYGIENE; MUCOSA INFLAMMATION; PAIN; PATHOGENESIS; PHOTOTHERAPY; PRACTICE GUIDELINE; PRIORITY JOURNAL; STOMATITIS;

HUMANS; INFORMATION DISSEMINATION; MEDICAL ONCOLOGY; NEOPLASMS; PRACTICE GUIDELINES AS TOPIC; STOMATITIS;

EID: 84885669117     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-013-1924-2     Document Type: Editorial

References (16)

1. Lalla RV (2013) The MASCC/ISOO Mucositis Guidelines Update: introduction to the first set of articles. Support Care Cancer 21(1):301-302. doi: 10.1007/s00520-012-1660-z
2. Bowen JM, Elad S, Hutchins RD, Lalla RV, Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (2013) Methodology for the MASCC/ISOO Mucositis Clinical Practice Guidelines Update. Support Care Cancer 21(1):303-308. doi: 10.1007/s00520-012- 1592-7
3. Elad S, Bowen J, Zadik Y, Lalla RV (2013) Development of the MASCC/ISOO Clinical Practice Guidelines for Mucositis: considerations underlying the process. Support Care Cancer 21(1):309-312. doi: 10.1007/s00520-012-1593-6
4. Gibson RJ, Keefe DM, Lalla RV, Bateman E, Blijlevens N, Fijlstra M, King EE, Stringer AM, van der Velden WJ, Yazbeck R, Elad S, Bowen JM, Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (2013) Systematic review of agents for the management of gastrointestinal mucositis in cancer patients. Support Care Cancer 21(1):313-326. doi: 10.1007/s00520-012-1644-z
5. Peterson DE, Ohrn K, Bowen J, Fliedner M, Lees J, Loprinzi C, Mori T, Osaguona A, Weikel DS, Elad S, Lalla RV, Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (2013) Systematic review of oral cryotherapy for management of oral mucositis caused by cancer therapy. Support Care Cancer 21(1):327-332. doi: 10.1007/s00520-012-1562-0
6. Migliorati C, Hewson I, Lalla RV, Antunes HS, Estilo CL, Hodgson B, Lopes NN, Schubert MM, Bowen J, Elad S, Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (2013) Systematic review of laser and other light therapy for the management of oral mucositis in cancer patients. Support Care Cancer 21(1):333-341. doi: 10.1007/s00520-012-1605-6
7. Raber-Durlacher JE, von Bultzingslowen I, Logan RM, Bowen J, Al-Azri AR, Everaus H, Gerber E, Gomez JG, Pettersson BG, Soga Y, Spijkervet FK, Tissing WJ, Epstein JB, Elad S, Lalla RV, Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (2013) Systematic review of cytokines and growth factors for the management of oral mucositis in cancer patients. Support Care Cancer 21(1):343-355. doi: 10.1007/s00520-012-1594-5
8. Nicolatou-Galitis O, Sarri T, Bowen J, Di Palma M, Kouloulias VE, Niscola P, Riesenbeck D, Stokman M, Tissing W, Yeoh E, Elad S, Lalla RV, Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (2013) Systematic review of amifostine for the management of oral mucositis in cancer patients. Support Care Cancer 21(1):357-364. doi: 10.1007/s00520-012-1613-6
9. Boers-Doets CB, Epstein JB, Raber-Durlacher JE, Ouwerkerk J, Logan RM, Brakenhoff JA, Lacouture ME, Gelderblom H (2012) Oral adverse events associated with tyrosine kinase and mammalian target of rapamycin inhibitors in renal cell carcinoma: a structured literature review. Oncologist 17(1):135-144. doi: 10.1634/theoncologist.2011-0111
10. Peterson DE, Bensadoun RJ, Roila F, ESMO Guidelines Working Group (2010) Management of oral and gastrointestinal mucositis: ESMO Clinical Practice Guidelines. Ann Oncol 21(Suppl 5):v261-265. doi: 10.1093/annonc/mdq197
11. Bensinger W, Schubert M, Ang KK, Brizel D, Brown E, Eilers JG, Elting L, Mittal BB, Schattner MA, Spielberger R, Treister NS, Trotti AM 3rd (2008) NCCN task force report. prevention and management of mucositis in cancer care. J Natl Compr Cancer Netw: JNCCN 6(Suppl 1):S1-21, quiz S22-24
12. Harris DJ, Eilers J, Harriman A, Cashavelly BJ, Maxwell C (2008) Putting evidence into practice: evidence-based interventions for the management of oral mucositis. Clin J Oncol Nurs 12(1):141-152. doi: 10.1188/08.CJON.141-152
13. Peterson DE, Bensadoun RJ, Lalla RV, McGuire DB (2011) Supportive care treatment guidelines: value, limitations, and opportunities. Semin Oncol 38(3):367-373. doi: 10.1053/j.seminoncol.2011.03.005
14. Gagliardi AR (2012) Translating knowledge to practice: optimizing the use of guidelines. Epidemiol Psychiatr Sci 21(3):231-236. doi: 10.1017/ S2045796012000212
15. Boaz A, Baeza J, Fraser A, European Implementation Score Collaborative Group (2011) Effective implementation of research into practice: an overview of systematic reviews of the health literature. BMC research notes 4:212. doi: 10.1186/1756-0500-4-212
16. Grimshaw JM, Schunemann HJ, Burgers J, Cruz AA, Heffner J, Metersky M, Cook D, Ad Hoc Committee on Integrating Coordinating Efforts in COPD Guideline Development (2012) Disseminating and implementing guidelines: article 13 in integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report. Proc Am Thorac Soc 9(5):298-303. doi: 10.1513/pats.201208-066ST